Produced through a proprietary process, it delivers a uniform distribution of β tri-calcium phosphate particles, fully integrated into a poly-L-lactic acid (PLLA) matrix to maximise component integrity. Bilok utilises a low molecular weight and low crystalline PLLA for improved degradation times and hydrophilicity.

The Doubleplay^® suture implant, manufactured from Bilok, is a novel, fully threaded anchor intended to reattach soft tissue to bone. The innovative 'eyeless' design eliminates the risk of eyelet breakage – a feature that is unique to screw-in anchors.

Bilok has the longest clinical pedigree of all calcium-based composite materials now entering the market.¹

Reference: 1. Barber, F.A. and W.D. Dockery, Long-term absorption of beta-tricalcium phosphate poly-L-lactic acid interference screws. Arthroscopy, 2008. 24(4): p. 441-7.

For indications, contraindications, warnings and precautions see Instructions for Use.

©2017, Biocomposites and Bilok are registered trademarks of Biocomposites Ltd. All rights reserved. No unauthorized copying, reproduction, distributing or re-publication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd.

Patents Granted: EP 1436019 B1, US 8563024, CN ZL02825134.2, EP 1954199 B1, US 8409251